title: Levosimendan for the treatment of acute heart failure syndromes: time to identify subpopulations of responding patients.
authors.forename: John T
authors.initials: JT
authors.lastname: Parissis
authors.forename: Dimitrios
authors.initials: D
authors.lastname: Farmakis
authors.forename: Vassiliki
authors.initials: V
authors.lastname: Bistola
authors.forename: Stamatios
authors.initials: S
authors.lastname: Adamopoulos
authors.forename: Dimitrios Th
authors.initials: DT
authors.lastname: Kremastinos
mesh_terms: D002316:Cardiotonic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D006835:Hydrazones / Q000008:administration & dosage / Q000627:therapeutic use*; D018579:Patient Selection; D011724:Pyridazines / Q000008:administration & dosage / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D000077464:Simendan
chemical_list: D002316:Cardiotonic Agents; D006835:Hydrazones; D011724:Pyridazines; D000077464:Simendan